Q2 2025 Sanara Medtech Inc Earnings Call Transcript
Key Points
- Sanara MedTech Inc (SMTI) reported a 28% year-over-year increase in net revenue for the second quarter, reaching $25.8 million.
- The company achieved a significant improvement in profitability, with a net income of approximately $500,000, an improvement of $2.7 million from the previous year.
- Sanara MedTech Inc (SMTI) generated $4.7 million of segment adjusted EBITDA, marking a 239% increase.
- The company expanded its distributor network to over 400 distributors, up from more than 300 the previous year.
- Sanara MedTech Inc (SMTI) successfully completed the acquisition of CarePICS, enhancing its THP technology platform.
- The Tissue Health Plus (THP) segment reported a net loss of $2.5 million, compared to a net loss of $1.3 million the previous year.
- Operating expenses increased by $2.9 million or 14%, driven by higher sales and marketing spend and additional SG&A in the THP segment.
- The company has significant long-term debt of $44.2 million as of June 30, 2025.
- Sanara MedTech Inc (SMTI) is actively managing expenses in the THP segment to reduce cash investment, indicating financial constraints.
- The company is exploring strategic alternatives for the THP segment, suggesting potential challenges in achieving desired growth internally.
Good day, and welcome to the Sanara MedTech second quarter of 2025 earnings conference call. (Operator Instructions) The company issued its earnings release earlier today.
Before we begin, I would like to remind everyone that certain statements on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For more information about the risks and uncertainties involving forward-looking statements and factors that could cause actual results to differ materially from those projected or implied by forward-looking statements.
Please see the risk factors set forth in the company's most recent annual report on form 10-K as supplemented by the Risk Factors in the company's most recent quarterly reports on form 10-Q.
This call will also include references to certain non-GAAP measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings release available on the Investor Relations portion of our website.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
